|
1.
|
|
8 p, 704.8 KB |
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder : protocol and clinical characteristics of the INCAS study
/
Brynte, Christoffer (Karolinska Institutet (Estocolm, Suècia)) ;
Aeschlimann, Myriam (University of Bern) ;
Barta, Csaba (Semmelweis University) ;
Begeman, Alex Hendikus Abraham (De Hoop Ggz) ;
Bäcker, Amanda (Karolinska Institutet (Estocolm, Suècia)) ;
Crunelle, Cleo Lina (Vrije Universiteit Brussel) ;
Daigre, Constanza (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
De Fuentes-Merillas, Laura (Novadic-Kentron Addiction Care) ;
Demetrovics, Zsolt (University of Gibraltar) ;
Dom, Geert (PC Multiversum) ;
Grau-López, Lara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Icick, Romain (Université de Paris Cité) ;
Johnson, Brian (SUNY Upstate University) ;
Joostens, Peter (Alexianen Zorggroep Tienen) ;
Kapitány-Fövény, Máté (National Institute of Mental Health) ;
Karsinti, Emily (Université Paris-Nanterre) ;
Kiefer, Falk (Mannheim Center for Translational Neurosciences) ;
Konstenius, Maija (Karolinska Institutet (Estocolm, Suècia)) ;
Levin, Frances R. (New York State Psychiatric Institute) ;
Luderer, Mathias (University Hospital of Frankfurt (Alemanya)) ;
Markus, Wiebren (Iriszorg Addiction Care) ;
Matthys, Frieda (Vrije Universiteit Brussel) ;
Moggi, Franz (University Hospital of Psychiatry) ;
Palma-Álvarez, Raúl Felipe (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Paraskevopoulou, Maria (RadboudumcDonders Institute for Brain) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Schellekens, Arnt (Nijmegen Institute for Scientist Practitioners in Addiction) ;
Soravia, Leila M. (Südhang Clinic) ;
Therribout, Norman (Université Paris-Nanterre) ;
Thomas, Anil (NYU Grossman School of Medicine) ;
van de Glind, Geurt (University of Applied Sciences-Utrecht) ;
van Kernebeek, Michiel Willem (Vrije Universiteit Brussel) ;
Vollstädt-Klein, Sabine (University of Heidelberg) ;
Vorspan, Florence (Université de Paris Cité) ;
van den Brink, Wim (Amsterdam UMC. University Medical Center) ;
Franck, Johan (Karolinska Institutet (Estocolm, Suècia)) ;
Universitat Autònoma de Barcelona
Substance use disorders (SUD) often co-occur with attention deficit hyperactivity disorder (ADHD). Although the short-term effects of some specific interventions have been investigated in randomized clinical trials, little is known about the long-term clinical course of treatment-seeking SUD patients with comorbid ADHD. [...]
2022 -  10.1186/s12888-022-04259-6
BMC Psychiatry, Vol. 22 (september 2022)
|
|
|
2.
|
|
6 p, 285.2 KB |
Early developmental, temperamental and educational problems in 'substance use disorder' patients with and without ADHD. Does ADHD make a difference?
/
Skutle, Arvid (Bergen Clinics Foundation, Bergen, Norway) ;
Bu, Eli Torild Hellandsjø (Bergen Clinics Foundation, Bergen, Norway) ;
Jellestad, Finn Konow (Department of Biological and Medical Psychology, University of Bergen, Norway) ;
van Emmerik-van Oortmerssen, Katelijne (The Netherlands Arkin, Amsterdam, The Netherlands) ;
Dom, Geert (Collaborative Antwerp Psychiatry Research Institute (Anvers, Bèlgica)) ;
Verspreet, Sofie (Collaborative Antwerp Psychiatry Research Institute (Anvers, Bèlgica)) ;
Carpentier, Pieter Jan (Reinier van Arkel groep, 's-Hertogenbosch, The Netherlands) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Franck, Johan (Karolinska Institutet (Estocolm, Suècia). Department of Clinical Neuroscience) ;
Konstenius, Maija (Karolinska Institutet (Estocolm, Suècia). Department of Clinical Neuroscience) ;
Kaye, Sharlene (National Drug and Alcohol Research Centre, UNSW Australia, Sydney, Australia) ;
Demetrovics, Zsolt (Institute of Psychology, Eötvös Loránd University, Budapest, Hungary) ;
Barta, Csaba (Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary) ;
Fatséas, Melina (Laboratoire de psychiatrie Département d'addictologie, Université de Bordeaux, Bordeaux, France) ;
Auriacombe, Marc (Laboratoire de psychiatrie Département d'addictologie, Université de Bordeaux, Bordeaux, France) ;
Johnson, Brian (Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA) ;
Faraone, Stephen V. (Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA) ;
Levin, Frances R. (Columbia University/the New York State Psychiatric Institute, New York, USA) ;
Allsop, Steve (National Drug Research Institute/Curtin University of Technology, Perth, Australia) ;
Carruthers, Susan (National Drug Research Institute/Curtin University of Technology, Perth, Australia) ;
Schoevers, Robert A. (Dept of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands) ;
Koeter, Maarten W. J. (Amsterdam UMC. University Medical Center) ;
van den Brink, Wim (Amsterdam UMC. University Medical Center) ;
Moggi, Franz (Bern University Hospital) ;
Møller, Merete (Sykehuset Østfold, Norway) ;
van de Glind, Geurt (Trimbos Instituut, ICASA Foundation, The Netherlands) ;
Universitat Autònoma de Barcelona
The prevalence of ADHD among patients with substance use disorder (SUD) is substantial. This study addressed the following research questions: Are early developmental, temperamental and educational problems overrepresented among SUD patients with ADHD compared to SUD patients without ADHD? Do this comorbid group receive early help for their ADHD, and are there signs of self-medicating with illicit central stimulants? An international, multi-centre cross-sectional study was carried out involving seven European countries, with 1205 patients in treatment for SUD. [...]
2015 - 10.1016/j.abrep.2015.03.001
Addictive Behaviors Reports, Vol. 2 (march 2015) , p. 13-18
|
|
|
3.
|
|
20 p, 358.8 KB |
Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients : Results from an international multi-center study exploring DSM-IV and DSM-5 criteria
/
van de Glind, Geurt (Amsterdam UMC. University Medical Center) ;
Koeter, Maarten W. J. (Amsterdam UMC. University Medical Center) ;
van Emmerik-van Oortmerssen, Katelijne (Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands) ;
Carpentier, Pieter Jan (Reinier van Arkel groep, 's-Hertogenbosch, The Netherlands) ;
Kaye, Sharlene (National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia) ;
Degenhardt, Louisa (Melbourne School of Population and Global Health, University of Melbourne, Australia) ;
Skutle, Arvid (Bergen Clinics Foundation, Bergen, Norway) ;
Franck, Johan (Karolinska Institutet (Estocolm, Suècia). Department of Clinical Neuroscience) ;
Bu, Eli Torild Hellandsjø (Bergen Clinics Foundation, Bergen, Norway) ;
Moggi, Franz (University Hospital of Psychiatry Bern and Department of Psychology, University of Fribourg, Fribourg, Switzerland) ;
Dom, Geert (Collaborative Antwerp Psychiatry Research Institute (Anvers, Bèlgica)) ;
Verspreet, Sofie (Collaborative Antwerp Psychiatry Research Institute (Anvers, Bèlgica)) ;
Demetrovics, Zsolt (Institute of Psychology, Eötvös Loránd University, Budapest, Hungary) ;
Kapitány-Fövény, Máté (Nyíro Gyula Hospital Drug Outpatient and Prevention Center, Budapest, Hungary) ;
Fatséas, Melina (Laboratoire de psychiatrie, Sanpsy CNRS USR 3413, Université de Bordeaux, and Département d'addictologie, CH Ch. Perrens/CHU de Bordeaux, Bordeaux, France) ;
Auriacombe, Marc (Laboratoire de psychiatrie, Sanpsy CNRS USR 3413, Université de Bordeaux, and Département d'addictologie, CH Ch. Perrens/CHU de Bordeaux, Bordeaux, France) ;
Schillinger, Arild (Østfold Hospital Trust, Department for Substance Abuse Treatment, Norway) ;
Møller, Merete (Østfold Hospital Trust, Department for Substance Abuse Treatment, Norway) ;
Johnson, Brian (Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA) ;
Faraone, Stephen V. (Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Casas Brugué, Miquel (Hospital Universitari Vall d'Hebron) ;
Allsop, Steve (National Drug Research Institute/Curtin University of Technology, Perth, Australia) ;
Carruthers, Susan (National Drug Research Institute/Curtin University of Technology, Perth, Australia) ;
Schoevers, Robert A. (Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands) ;
Wallhed, Sara (Stockholm Centre for Dependency Disorders, Sweden) ;
Barta, Csaba (Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary) ;
Alleman, Peter (Alcohol Treatment Research, Kirchlindach and Ellikon, Switzerland) ;
Levin, Frances R. (Columbia University/New York State Psychiatric Institute, New York City, NY, USA) ;
van den Brink, Wim (Amsterdam UMC. University Medical Center) ;
Konstenius, Maija (Karolinska Institutet (Estocolm, Suècia). Department of Clinical Neuroscience) ;
Universitat Autònoma de Barcelona
Available studies vary in their estimated prevalence of attention deficit/hyperactivity disorder (ADHD) in substance use disorder (SUD) patients, ranging from 2 to 83%. A better understanding of the possible reasons for this variability and the effect of the change from DSM-IV to DSM-5 is needed. [...]
2013 - 10.1016/j.drugalcdep.2013.09.026
Drug and alcohol dependence, Vol. 134 (october 2013) , p. 158-166
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
